Vistas Media Acquisition Company (NASDAQ:VMAC) announced in a press release today that its shareholders have approved its combination with streaming service Anghami in a special meeting held yesterday.
VMAC saw 9,757,033 shares redeemed, representing 97.57% of pubic shareholders, leaving just 242,967 public SPAC shares post-vote. This is most likely going to cause a “low-float” trading situation, which is already evident in after-hours trading. VMAC’s share price is currently up approximately 25% to $10.70 after closing this afternoon at $8.55. However, approximately 98% of the votes cast at the meeting were in favor of the business combination.
The parties expect to close the deal shortly, and the combined company’s common stock and warrants are expected to begin trading on the NASDAQ under the tickers “ANGH” and “ANGHW,” respectively.
The parties initially announced their $220 million deal on March 3. Angahmi provides streaming music through both paid and free users in the Middle East and North Africa.
All other proposals listed on the ballot, including the adjournment and Nasdaq proposal, were also approved at today’s meeting.
ADVISORS
- deNovo acted as financial advisor and Winston & Strawn LLP acted as legal advisor to VMAC and its parent company Vistas Media Capital.
- SHUAA Capital acted as financial advisor and global underwriter and Norton Rose Fulbright acted as legal advisor to Anghami.
- Baker Botts L.L.P. acted as US counsel to SHUAA Capital.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...